Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 227

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study

Open access
Calligaro, Gregory L., Lalla, Usha, Audley, Gordon, Gina, Phindile, Miller, Malcolm G., Mendelson, Marc, Dlamini, Sipho, Wasserman, Sean, Meintjes, Graeme, Peter, Jonathan, Levin, Dion, Dave, Joel A., Ntusi, Ntobeko, Meier, Stuart, Little, Francesca, Moodley, Desiree L., Louw, Elizabeth H., Nortje, Andre, Parker, Arifa, Taljaard, Jantjie J., Allwood, Brian W., Dheda, Keertan, Koegelenberg, Coenraad F.N. · 2020 · EClinicalMedicine

Abstract

Background The utility of heated and humidified high-flow nasal oxygen (HFNO) for severe COVID-19-related hypoxaemic respiratory failure (HRF), particularly in settings with limited access to intensive care unit (ICU) resources, remains unclear, and predictors of outcome have been poorly studied. Methods We included consecutive patients with COVID-19-related HRF treated with HFNO at two tertiary hospitals in Cape Town, South Africa. The primary outcome was the proportion of patients who were successfully weaned from HFNO, whilst failure comprised intubation or death on HFNO. Findings The median (IQR) arterial oxygen partial pressure to fraction inspired oxygen ratio (P a O2/FiO 2 ) was 68 (54–92) in 293 enroled patients. Of these, 137/293 (47%) of patients [P a O2/FiO 2 76 (63–93)] were successfully weaned from HFNO. The median duration of HFNO was 6 (3–9) in those successfully treated versus 2 (1–5) days in those who failed ( p <0.001). A higher ratio of oxygen saturation/FiO2 to respiratory rate within 6 h (ROX-6 score) after HFNO commencement was associated with HFNO success (ROX-6; AHR 0.43, 0.31–0.60), as was use of steroids (AHR 0.35, 95%CI 0.19–0.64). A ROX-6 score of ≥3.7 was 80% predictive of successful weaning whilst ROX-6 ≤ 2.2 was 74% predictive of failure. In total, 139 patents (52%) survived to hospital discharge, whilst mortality amongst HFNO failures with outcomes was 129/140 (92%). Interpretation In a resource-constrained setting, HFNO for severe COVID-19 HRF is feasible and more almost half of those who receive it can be successfully weaned without the need for mechanical ventilation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eclinm.2020.100570

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 227

Metadata

Authors
Calligaro, G. L., Lalla, U., Audley, G., Gina, P., Miller, M. G., Mendelson, M., Dlamini, S., Wasserman, S., Meintjes, G., Peter, J., Levin, D., Dave, J. A., Ntusi, N., Meier, S., Little, F., Moodley, D. L., Louw, E. H., Nortje, A., Parker, A., Taljaard, J. J., Allwood, B. W., Dheda, K., & Koegelenberg, C. F. N.
Venue
EClinicalMedicine
Publisher
Elsevier BV
Published
2020-11
Volume
28
Pages
100570
ISSN
2589-5370 (ISSN-L)
OpenAlex
W3089710067
Cited by
227
References
6
FWCI
23.64
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study. https://app.cochat.ai/papers/10.1016/j.eclinm.2020.100570
The paper
Calligaro, G. L., Lalla, U., Audley, G., Gina, P., Miller, M. G., Mendelson, M., Dlamini, S., Wasserman, S., Meintjes, G., Peter, J., Levin, D., Dave, J. A., Ntusi, N., Meier, S., Little, F., Moodley, D. L., Louw, E. H., Nortje, A., Parker, A., . . . Koegelenberg, C. F. N. (2020). The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2020.100570

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.